APA (7th ed.) Citation

Négrier, C., Abdul Karim, F., Lepatan, L. M., Lienhart, A., López-Fernández, M. F., Mahlangu, J., . . . Santagostino, E. (2016). Efficacy and safety of long-acting recombinant fusion protein linking factor IX with albumin in haemophilia B patients undergoing surgery. Haemophilia : the official journal of the World Federation of Hemophilia, 22(4), e259-e266. https://doi.org/10.1111/hae.12972

Chicago Style (17th ed.) Citation

Négrier, C., et al. "Efficacy and Safety of Long-acting Recombinant Fusion Protein Linking Factor IX with Albumin in Haemophilia B Patients Undergoing Surgery." Haemophilia : The Official Journal of the World Federation of Hemophilia 22, no. 4 (2016): e259-e266. https://doi.org/10.1111/hae.12972.

MLA (9th ed.) Citation

Négrier, C., et al. "Efficacy and Safety of Long-acting Recombinant Fusion Protein Linking Factor IX with Albumin in Haemophilia B Patients Undergoing Surgery." Haemophilia : The Official Journal of the World Federation of Hemophilia, vol. 22, no. 4, 2016, pp. e259-e266, https://doi.org/10.1111/hae.12972.